- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07821632
Predictors of Prolonged Mechanical Ventilation in Preterm Infants
Predictors of Prolonged Mechanical Ventilation in Preterm Infants Admitted to Neonatal Intensive Care Unit of Assiut University Children Hospital
Study Overview
Status
Detailed Description
Prolonged mechanical ventilation in preterm infants is associated with increased morbidity including bronchopulmonary dysplasia and neurodevelopmental impairment. This prospective observational study will include preterm infants (born before 37 completed weeks) who require invasive mechanical ventilation.
Infants will be classified into two groups according to the duration of invasive mechanical ventilation: prolonged (>7 days or frequent reintubation) and non-prolonged (≤7 days). clinical, perinatal, and laboratory predictors of prolonged mechanical ventilation will be evaluated.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Demiana Y Zakaria, Resident
- Phone Number: 0 1280798683
- Email: Demiana.16266368@med.aun.edu.eg
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- - Preterm infants born before 37 completed weeks of gestation
- Admission to the NICU within the neonatal period
- Requirement for invasive mechanical ventilation
- Written informed consent from parents or legal guardians
Exclusion Criteria:
- - Infants born after 37 weeks of gestation
- Major congenital anomalies
- Chromosomal abnormalities
- Congenital neuromuscular disorders
- Cyanotic congenital heart disease
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Prolonged Mechanical Ventilation
Preterm infants who require invasive mechanical ventilation for more than 7 days or frequent reintubation
|
|
Non-Prolonged Mechanical Ventilation
Preterm infants who require invasive mechanical ventilation for ≤7 days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Occurrence of prolonged mechanical ventilation
Time Frame: Up to 30 days
|
Proportion of preterm infants who require invasive mechanical ventilation for more than 7 days or frequent reintubation.
|
Up to 30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Duration of NICU stay
Time Frame: Up to 30 days
|
Length of stay in the neonatal intensive care unit in days.
|
Up to 30 days
|
|
Duration of invasive mechanical ventilation
Time Frame: Up to 30 days
|
Total number of days of invasive mechanical ventilation.
|
Up to 30 days
|
|
Successful extubation rate
Time Frame: Up to 30 days
|
Proportion of infants who are successfully extubated without re-intubation within 48-72 hours.
|
Up to 30 days
|
|
Incidence of bronchopulmonary dysplasia
Time Frame: Up to 30 days
|
Proportion of infants diagnosed with bronchopulmonary dysplasia.
|
Up to 30 days
|
|
Incidence of neonatal sepsis
Time Frame: Up to 30 days
|
Proportion of infants diagnosed with neonatal sepsis.
|
Up to 30 days
|
|
In-hospital mortality
Time Frame: Up to 30 days
|
Proportion of infants who die before hospital discharge.
|
Up to 30 days
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Jaafar I Mohammed, prof, pediatrics Department, Assiut University Hospitals
Publications and helpful links
General Publications
- Vliegenthart RJS, van Kaam AH, Aarnoudse-Moens CSH, van Wassenaer AG, Onland W. Duration of mechanical ventilation and neurodevelopment in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2019 Nov;104(6):F631-F635. doi: 10.1136/archdischild-2018-315993. Epub 2019 Mar 20.
- Zeiler SR, Hubbard R, Gibson EM, Zheng T, Ng K, O'Brien R, Krakauer JW. Paradoxical Motor Recovery From a First Stroke After Induction of a Second Stroke: Reopening a Postischemic Sensitive Period. Neurorehabil Neural Repair. 2016 Sep;30(8):794-800. doi: 10.1177/1545968315624783. Epub 2015 Dec 31.
- Li Z, He Z, Wang J, Kong G. RNA splicing factors in normal hematopoiesis and hematologic malignancies: novel therapeutic targets and strategies. J Leukoc Biol. 2023 Feb 1;113(2):149-163. doi: 10.1093/jleuko/qiac015.
- La Croce G, Naspro R, Finati M, Pellucchi F, Sodano M, Manica M, Catellani M, Gianatti A, Roscigno M, Da Pozzo LF. The Accuracy of Transurethral Bladder Resection in Detecting Bladder Cancer Histological Variants and Their Prognostic Value at Radical Cystectomy. J Clin Med. 2022 Jan 22;11(3):550. doi: 10.3390/jcm11030550.
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Urogenital Diseases
- Pathologic Processes
- Female Urogenital Diseases and Pregnancy Complications
- Obstetric Labor, Premature
- Obstetric Labor Complications
- Pregnancy Complications
- Respiratory Tract Diseases
- Lung Diseases
- Respiration Disorders
- Infant, Premature, Diseases
- Infant, Newborn, Diseases
- Lung Injury
- Ventilator-Induced Lung Injury
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities
- Pathological Conditions, Signs and Symptoms
- Premature Birth
- Respiratory Insufficiency
- Respiratory Aspiration
- Bronchopulmonary Dysplasia
Other Study ID Numbers
- PMV-Preterm-NICU-Assiut-2026
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.